Author:
Joshi Harshad,Lewis Kristen,Singharoy Abhishek,Ortoleva Peter J.
Funder
National Science Foundation (Collaborative Research in Chemistry program)
National Institute of Health (NIBIB)
METAcyt
Indiana University College of Arts and Sciences
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference50 articles.
1. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design;Plummer;Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology,2011
2. Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic;López-Macías;Human Vaccines and Immunotherapeutics,2012
3. Virus-like particles (VLPs) as anti-viral vaccines: an effective approach for a HIV-1 vaccine strategy;Buonaguro;ASHI Quarterly,2005
4. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs);Mach;Journal of Pharmaceutical Sciences,2006
5. Therapeutic VLP-based vaccines for chronic diseases;Jennings;Annual Review of Pharmacology and Toxicology,2009
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献